Despite studies including patients with high Sequential Organ Failure Assessment scores, refractory hyperglycaemia and increased insulin requirements, hybrid protocols using rtCGM resulted in acceptable glycaemic control with a low incidence of hypoglycaemia, as evidenced by the time in, above and below range data. This evidence concerns the gene INS and Hyperglycemia.